Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Cancer · Esophageal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Taiwan University Hospital Yunlin Branch, Huwei, Yunlin County, Taiwan

Study leads

Yen-Ting Liu, MD
Principal Investigator
National Taiwan University Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Pittsburgh, United States · Natal, Brazil

Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Esophageal Squamous Cell Carcinoma · Ivonescimab · Neoadjuvant

Abroad (travel likely)RecruitingPHASE1, PHASE2

Xi'an, China

Oncolytic Virus in Esophageal Squamous Cell Carcinoma

Esophageal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chengdu, China